Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05371834 · ClinicalTrials.gov registry record · NA
Microwave Treatment of Common and Plantar Warts
A NA study of Warts, sponsored by Blackwell Device Consulting.
- Active
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 6
- Study locations
NCT05371834: Active NA study of Warts, sponsored by Blackwell Device Consulting.
NCT05371834 is a NA study of Warts that is active but no longer recruiting, run by Blackwell Device Consulting. The registered enrollment target is 119 participants, below the 205-participant average among 7 other Warts trials with a reported enrollment target (42% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05371834, a NA study of Warts, is active but no longer recruiting, sponsored by Blackwell Device Consulting.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a multi-center, open, randomized, parallel-group, controlled, blind-assessed trial of approximately 124 subjects that require treatment for up to 5 common or plantar warts. Subjects will be randomized to one of two treatment groups: Microwave Treatment (Swift® system) or Cryotherapy.
Conditions Studied
Interventions
- DEVICE Cryotherapy
- DEVICE Microwave Treatment (Swift System)
Study Locations (6)
Florida
- Miami Dermatology and Laser Institute - Miami
- TrueBlue Clinical Research - Palm Harbor
- TrueBlue Clinical Research - Tampa
Illinois
- Weil Foot & Ankle Institute - Chicago
- Oak Dermatology - Naperville
Tennessee
- Tennessee Clinical Research Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2022-07-06 |
| Est. Completion | 2025-03 |
| Phase | NA |
What the registry record for NCT05371834 still lists
NCT05371834 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 205-participant average among 7 other Warts trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Warts appearing as the primary indexed condition, and to 2 interventions - of which Cryotherapy is the first listed.
NCT05371834 lists 6 locations in 3 states (Florida, Illinois, Tennessee).
Frequently Asked Questions
What is clinical trial NCT05371834 about?
NCT05371834 is a clinical study titled "Microwave Treatment of Common and Plantar Warts". This is a multi-center, open, randomized, parallel-group, controlled, blind-assessed trial of approximately 124 subjects that require treatment for up to 5 common or plantar warts. Subjects will be randomized to one of two treatment groups: Microwave Treatment (Swift® system) or Cryotherapy.
What is the current status of trial NCT05371834?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 119 participants. The study started on 2022-07-06. Estimated completion is 2025-03.
What conditions does trial NCT05371834 study?
This clinical trial studies the following conditions: Warts.
What interventions are being tested in trial NCT05371834?
The interventions under investigation include: Cryotherapy (DEVICE), Microwave Treatment (Swift System) (DEVICE).
Who is sponsoring clinical trial NCT05371834?
This trial is sponsored by Blackwell Device Consulting, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05371834 being conducted?
This trial has 6 study locations across Florida, Illinois, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Warts
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
COMPLETED · NA
-
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
RECRUITING · Phase 1
-
Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
RECRUITING · Phase 2
-
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
RECRUITING
-
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
RECRUITING · Phase 3
-
Candin Safety & Efficacy Study for the Treatment of Warts
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI